Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06170645

Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue

Chronic fatigue is enhanced by adapted physical activity (APA) programs. Patients consulting on St Etienne hospital and suffering from fibromyalgia and long Covid benefit from a 4-6 week APA program, with 2 sessions per week. While most patients are improved by these exercise-training programs, for some the benefits remain very modest, and patients describe persistent fatigue. The literature unanimously describes the necessity of longer APA protocols (8-12 weeks, 2-3 sessions/week) for fatigue reduction in fibromyalgia and long Covid. However, it seems difficult to adhere to an optimal program as described in the literature for these fatigued patients. The investigators want to test a device that would both reduce fatigue and improve recovery between APA sessions, in order to gradually reach the recommendations for APA practice. Transcutaneous vagal nerve stimulation (tVNS) seems to be a promising approach. Thus, combining an APA intervention with a tVNS protocol could potentiate the expected and now well-known effect of exercise.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier de Saint-Etienne

Saint-Etienne, 42055, France

Location status: Recruiting

Location contact

David HUPIN, MD

CONTACT

David HUPIN, MD

PRINCIPAL_INVESTIGATOR

Frédéric ROCHE, MD PhD

CONTACT

Frédéric ROCHE, MD PhD

SUB_INVESTIGATOR

Léonard FEASSON, MD PhD

SUB_INVESTIGATOR

Philippe BOIRON, MD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over 18 years old
  • Signature of informed consent
  • Confirmed diagnosis of fibromyalgia or long Covid (ACR 2016 criteria and persistent symptoms lasting more than 6 months after a positive RT-PCR test, respectively)
  • Persistent fatigue after an exercise rehabilitation program (FSS score > 36)
  • Physical inactivity, i.e. <150 minutes per week of physical activity

Exclusion criteria

  • Pre-existing atrial fibrillation,
  • Left ventricular ejection fraction <40%
  • Severe heart failure
  • Recent stroke or myocardial infarction (<6 months)
  • Unilateral or bilateral vagotomy
  • Pregnancy or breastfeeding

Treatment and study plan

APA Program

Other

An APA program of 12 weeks, 2 sessions of 1h/week for mixed endurance, strengthening and stretching work. The program can be realized at home or in structure.

Active transcutaneous VNS

Other

After each APA session, a 1h-tVNS session is delivered on the conchae aurea of the left ear, in resting condition. Parameters of tVNS : frequency 20Hz, impulsion 200ms, amplitude 1mA below the unpleasant sensation level.

Sham transcutaneous VNS

Other

After each APA session, a 1h-tVNS session is delivered on the left earlobe, in resting condition. Parameters of tVNS : frequency 20Hz, impulsion 200ms, amplitude 1mA below the unpleasant sensation level.

Primary outcomes

  1. Fatigue evaluation assessed by autonomic nervous system activity

    Time frame: Month : 0; 3

    The root mean square of successive differences in heart rate (in milliseconds) will be measured from a nocturnal Holter ECG recording (Novacor, Paris, France) at the end of the 3-month APA and tVNS programme (month 3) and compared with pre-programme values (inclusion).

Secondary outcomes

  1. Fatigue Severity Scale (FSS)

    Time frame: Month : 0; 6

    Subjective fatigue assessed by FSS, score from 9 to 63. The higher the score, the more severe the fatigue is and the more it affects the person's activities.

  2. Medical Outcome Study Short Form questionnaire (MOS-SF 12)

    Time frame: Month : 0; 6

    Quality of life assessed by the MOS-SF 12 questionnaire , score from 0 to 100. A low score reflects a perception of poor health, loss of function and the presence of pain. A high score reflects a perception of good health, absence of functional deficit and pain.

  3. Pittsburgh questionnaire

    Time frame: Month : 0; 6

    Quality of sleep assessed by Pittsburgh questionnaire (score 0 to 21). The 7 components of the score add up to give an overall score ranging from give an overall score ranging from 0 to 21 points, with 0 meaning that there are no difficulties, and 21 indicating major difficulties.

  4. 6-minute walk test (6MWT)

    Time frame: Month : 0; 6

    Physical condition assessed by the walking distance covered in the 6MWT, walking distance in m.

  5. Adult Physical Activity Questionnaire (APAQ)

    Time frame: Month : 0; 6

    Physical activity assessed by the APAQ, time spend to physical activity in hours/day.

  6. Step count per day

    Time frame: Month : 0; 6

    Objective physical activity assessed by step count per day using a Garmin Vivofit 4 activity tracker.

  7. Ratio of Low Frequency to High Frequency (LF/HF)

    Time frame: Month : 0; 6

    The autonomic balance (sympathetic/parasympathetic) will be analysed by measuring the LF/HF ratio on the basis of a nocturnal Holter ECG recording (Novacor, Paris, France).

Study contacts

Contact information is provided by the study sponsor or research team.

David HUPIN, MD

CONTACT

[email protected]

(0)4 77 82 84 13 ext. +33

Hélène RAINGARD, CRA

CONTACT

[email protected]

(0)4 77 12 08 26 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue: Single-center, Controlled, Randomized, Blinded Study

Acronym: PAF-tVNS

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Dec 14, 2023
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.